Dis Manag Advis. 2005 Jan;11(1):8-10, 1.
Disease management advisor
[No authors listed]
PMID: 15766057
There is new evidence that the most common method for assessing risk of CVD--the Framingham Risk Estimate or FRE--fails to identify a significant number of women who could benefit from aggressive preventive therapies. As a result, investigators are urging clinicians to supplement the FRE with other screening methodologies, at least in some cases.